EUVIMEDSkopri EUVIMED
Crossref

Plasma ANGPTL7 Links Insulin Resistance to Heart Failure: Unveiling a Novel Fibro‐Metabolic Axis in Type 2 Diabetes

Yanjun Song, Xinyue Chen, Zhen'ge Chang, Chunyue Wang, Zhihao Zheng, Zhangyu Lin, Bowen Li, Chen Zhu iD, Xiao Wang, Rui Fu, Kefei Dou iD

Diabetes/Metabolism Research and Reviews · 2026-03 · 42 (3)

DOI: 10.1002/dmrr.70153 ↗

At a glance

Journal article in Diabetes/Metabolism Research and Reviews, published online on 2026-03-10. Written by Yanjun Song and 10 co-authors. Institution: State Key Laboratory of Cardiovascular Disease, Beijing, China. Major MEDLINE topics: Diabetes Mellitus, Type 2, Insulin Resistance, Heart Failure, Biomarkers. 34 references. Funded by: Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aims

Heart failure (HF) is a major cardiovascular complication of type 2 diabetes mellitus (T2DM), yet reliable biomarkers for early risk stratification remain limited. We investigated the prospective association between plasma angiopoietin‐like protein 7 (ANGPTL7) and incident HF, and examined the extent to which this relationship is mediated by insulin resistance (IR). Materials and Methods This study included 2871 participants with T2DM and no baseline HF from the UK Biobank. Plasma ANGPTL7 was quantified using the Olink Proximity Extension Assay. Incident HF was ascertained via hospital and death records over a median follow‐up of 13.5 years. Multivariable Cox proportional hazards models and restricted cubic splines (RCS) were employed to estimate hazard ratios (HRs) and evaluate dose‐response relationships. Predictive performance was assessed using time‐dependent receiver operating characteristic (ROC) curves. Furthermore, we conducted stratified analyses by HF polygenic risk score (PRS) and performed causal mediation analysis to quantify the contributions of IR indices.

Results

Elevated ANGPTL7 levels were robustly associated with an increased risk of incident HF. Patients in the highest tertile had a 1.90‐fold higher risk compared to the lowest (HR 1.90, 95% CI 1.47–2.45, p < 0.001). This positive association was linear ( p for nonlinearity = 0.988). Time‐dependent ROC analysis showed that the AUCs for ANGPTL7 in predicting 5‐, 10‐, and 15‐year incident HF were 0.651, 0.666, and 0.670, respectively. Significant risk elevations for ANGPTL7 T3 versus T1 were consistent in both low‐PRS (HR 3.20, 95% CI 1.91–5.36) and high‐PRS groups (HR 1.75, 95% CI 1.14–2.69). Mechanistically, IR significantly mediated this association, with TyG‐WC and METS‐IR accounting for 19.4% and 9.0% of the total effect, respectively.

Conclusions

In T2DM patients, elevated plasma ANGPTL7 is an independent risk factor for future HF, showing a linear dose‐response relationship partially mediated by IR. ANGPTL7 may represent a promising biomarker and a potential therapeutic target warranting further investigation.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Insulin ResistanceHeart FailureBiomarkersAngiopoietin-like ProteinsHumansFemaleMaleMiddle AgedAngiopoietin-Like Protein 7Prospective StudiesFollow-Up StudiesPrognosisRisk FactorsAgedIncidence

Author keywords

angiopoietin‐like protein 7heart failureinsulin resistancepolygenic risk scorerisk stratificationtype 2 diabetes mellitus

Substances

BiomarkersAngiopoietin-like ProteinsAngiopoietin-Like Protein 7ANGPTL7 protein, human

Authors and institutions

  • State Key Laboratory of Cardiovascular Disease, Beijing, China.
  • Cardiometabolic Medicine Center, Department of Cardiology, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital, Beijing, China.
  • Coronary Heart Disease Center, Department of Cardiology, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital, Beijing, China.
  • College of Economics and Management, China Agricultural University, Beijing, China.
  • Emergency and Critical Care Center, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital, Beijing, China.

ORCID profiles: Chen Zhu, Kefei Dou

Funding

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project

Cite

APA

Song, Y., Chen, X., Chang, Z., Wang, C., Zheng, Z., Lin, Z., Li, B., Zhu, C., Wang, X., Fu, R., & Dou, K. (2026). Plasma ANGPTL7 Links Insulin Resistance to Heart Failure: Unveiling a Novel Fibro‐Metabolic Axis in Type 2 Diabetes. Diabetes/Metabolism Research and Reviews, 42(3). https://doi.org/10.1002/dmrr.70153

Vancouver

Song Y, Chen X, Chang Z, Wang C, Zheng Z, Lin Z, et al. Plasma ANGPTL7 Links Insulin Resistance to Heart Failure: Unveiling a Novel Fibro‐Metabolic Axis in Type 2 Diabetes. Diabetes/Metabolism Research and Reviews. 2026;42(3). doi:10.1002/dmrr.70153

BibTeX
@article{Song2026,
  author = {Song, Yanjun and Chen, Xinyue and Chang, Zhen'ge and Wang, Chunyue and Zheng, Zhihao and Lin, Zhangyu and Li, Bowen and Zhu, Chen and Wang, Xiao and Fu, Rui and Dou, Kefei},
  title = {Plasma ANGPTL7 Links Insulin Resistance to Heart Failure: Unveiling a Novel Fibro‐Metabolic Axis in Type 2 Diabetes},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2026},
  volume = {42},
  number = {3},
  doi = {10.1002/dmrr.70153}
}
Start for free →